Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study

Sung Huang Laurent Tsai, Yu Hsuan Chen, Chi-Ya Yang, Ching-Yu Lee, Chia-Hsien Chen, Tsung-Jen Huang, Meng-Huang Wu, Hung-En Huang, Wei Cheng Chung James

Open source

DOI: 10.1007/s00198-026-07968-w
Published: 2026-04-10
Container: Osteoporosis International
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00198-026-07968-w,
  title = {Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study},
  author = {Sung Huang Laurent Tsai and Yu Hsuan Chen and Chi-Ya Yang and Ching-Yu Lee and Chia-Hsien Chen and Tsung-Jen Huang and Meng-Huang Wu and Hung-En Huang and Wei Cheng Chung James},
  year = {2026},
  journal = {Osteoporosis International},
  doi = {10.1007/s00198-026-07968-w},
  url = {https://doi.org/10.1007/s00198-026-07968-w}
}

RIS

TY  - JOUR
TI  - Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study
AU  - Sung Huang Laurent Tsai
AU  - Yu Hsuan Chen
AU  - Chi-Ya Yang
AU  - Ching-Yu Lee
AU  - Chia-Hsien Chen
AU  - Tsung-Jen Huang
AU  - Meng-Huang Wu
AU  - Hung-En Huang
AU  - Wei Cheng Chung James
PY  - 2026
JO  - Osteoporosis International
DO  - 10.1007/s00198-026-07968-w
UR  - https://doi.org/10.1007/s00198-026-07968-w
ER  -

APA

Tsai, S. H. L., Chen, Y. H., Yang, C., Lee, C., Chen, C., Huang, T., Wu, M., Huang, H., & James, W. C. C. (2026). Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-026-07968-w

Source records

crossref · retrieved 2026-09-25T06:33:24.554Z